---
title: Serum metabolomic profiling for patients with adenocarcinoma of the esophagogastric
  junction
date: '2022-04-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/35441991/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Zkrxt7ktlCbHBXEV3v65xxSnkSWNsJ1A6Fq3gBniKhGfIUslK&fc=20210907212339&ff=20220422211056&v=2.17.6
source: metablomics[MeSH Terms]
description: 'CONCLUSION: This is the first metabolomics study to identify serum metabolic
  signature of AEG. The distinguishing metabolites show a promising application on
  clinical diagnose and outcome prediction, and allow us to unveil several key metabolic
  variations coexisting in AEG, which may aid to understand the underlying metabolic
  ...'
---
CONCLUSION: This is the first metabolomics study to identify serum metabolic signature of AEG. The distinguishing metabolites show a promising application on clinical diagnose and outcome prediction, and allow us to unveil several key metabolic variations coexisting in AEG, which may aid to understand the underlying metabolic ...